Klaus Godl
Inventor
Stats
- 3 US patents issued
- 4 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 3 US Patents Issued
- 4 US Applications Filed
- 106 Total Citation Count
- Aug 16, 2012 Most Recent Filing
- Jul 29, 2003 Earliest Filing
Work History
| Patent Owner | Applications Filed | Year |
|---|---|---|
| GPC BIOTECH AG | 1
| 2003
|
| MAX-PLANCK-GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN E.V. | 2
| 2008
|
| EVOTEC (MUENCHEN) GMBH | 1
| 2012
|
| Evotec (München) GmbH | 2
| 2012
|
| BAYER PHARMA AKTIENGESELLSCHAFT | 2
| 2004
|
Inventor Addresses
| Address | Duration |
|---|---|
| Durer-Str.18A, DE | May 18, 06 - May 18, 06 |
| Krailling, DE | Aug 16, 07 - Feb 24, 15 |
| Martinsried, DE | Oct 09, 14 - May 03, 16 |
Technology Profile
| Technology | Matters | |
|---|---|---|
| A01N: | PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF | 1 |
| A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 1 |
| C07D: | HETEROCYCLIC COMPOUNDS | 1 |
Patents / Publication
| Patents / Publication # | Year of Publication / Issued | Title | Citations |
|---|---|---|---|
| 9328386 | 2016 | Markers for susceptibility to an inhibitor of an Src-family kinase | 0 |
| 8959984 | 2015 | Proteome-wide quantification of small molecule binding to cellular target proteins | 1 |
| 2014/0302,172 | 2014 | MARKERS FOR SUSCEPTIBILITY TO AN INHIBITOR OF AN SRC-FAMILY KINASE | 4 |
| 8084457 | 2011 | Pharmaceutically active 4,6-disubstituted aminopyrimidine derivatives as modulators of protein kinases | 72 |
| 2010/0279,891 | 2010 | Proteome-Wide Quantification of Small Molecule Binding to Cellular Target Proteins | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.